Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04875364
PHASE2

Do Endotypes Predict Response and Sequelae in OSA Patients

Sponsor: University of California, San Diego

View on ClinicalTrials.gov

Summary

This study will investigate why some people have Obstructive Sleep Apnea (OSA) and how the underlying cause may relate to OSA manifestations (including sleepiness and high blood pressure) and response to different therapeutic approaches (ie CPAP, eszopiclone, and supplemental oxygen). Understanding why someone has OSA could affect how best to treat that individual, but may also have an impact on what problems the disease might cause.

Key Details

Gender

All

Age Range

21 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

233

Start Date

2020-08-01

Completion Date

2026-02-11

Last Updated

2026-06-18

Healthy Volunteers

No

Interventions

DRUG

Eszopiclone

2mg of Eszopiclone just before going to sleep.

OTHER

Supplemental Oxygen

Constant oxygen flow at 4 Liters per minutes for the duration of time in bed via nasal cannula.

DEVICE

Continuous Positive Airway Pressure (CPAP)

A standard CPAP device will be provided using the settings as prescribed by the treating physician.

Locations (1)

Altman Clinical and Translational Research Institute Building

La Jolla, California, United States